Stalk us here
Powered by Fresh Ideas

Amai Proteins Expands Global Reach with Singapore Approval for Sweelin

World 21.05.2026
Source: www.beveragedaily.com
EN 中文 DE FR عربى
Amai Proteins has received approval from the Singapore Food Agency for its sweet protein, Sweelin. This follows its GRAS status in the US, enabling expansion in the Asia-Pacific region.
Amai Proteins Expands Global Reach with Singapore Approval for Sweelin

Israeli food-tech company Amai Proteins has achieved a significant milestone by obtaining regulatory approval from the Singapore Food Agency (SFA) for its sweet protein product, Sweelin. This approval allows Sweelin to be used across various applications, including food and beverages, confectionery, chewing gum, condiments, and dietary supplements. The Singapore approval comes shortly after Sweelin was granted Generally Recognized as Safe (GRAS) status in the United States earlier this year.

With these regulatory clearances, Amai Proteins is set to expand its commercialization efforts, particularly in the Asia-Pacific region. According to Amir Guttman, CEO of Amai Proteins, these approvals are pivotal in introducing sweet proteins to mainstream markets. The company is also seeking regulatory approval in Israel, with expectations to achieve this within the next few months. Future plans include targeting Canada, Latin America, and broader regions within Asia-Pacific.

Sweelin is characterized as a precision fermentation-derived sweet protein and is the first of its kind approved in Singapore. It is inspired by monellin, a sweet protein found in the serendipity berry native to West Africa. Unlike traditional sugars, Sweelin is a protein composed solely of amino acids, containing zero calories and capable of reducing sugar content by 40-70% in over 30 different applications. It maintains a clean taste profile and is stable under heat and varying pH conditions, overcoming challenges that have hindered alternative sweeteners.

The company is also working on clinical validation of its sweet proteins. Amai Proteins recently completed what it claims to be the first randomized controlled trial (RCT) on a sweet protein, demonstrating that Sweelin does not affect blood glucose, insulin, or GLP-1 levels. These results are expected to be published soon, aligning with industry trends focusing on metabolic health.

Amai Proteins employs precision fermentation to produce Sweelin, overcoming traditional supply challenges associated with sweet proteins extracted from natural sources. This method provides a consistent, scalable, and cost-effective production process, independent of environmental constraints.

In the United States, Sweelin can be labeled as “Serendipity Berry Sweet Protein,” supporting clean-label positioning. The protein's potency is notable, as 300 grams of Sweelin can replace up to 1,000 kilograms of sugar, allowing significant sugar reduction without compromising taste.